Next Article in Journal
Reply to “When Is a Ketogenic Diet Ketogenic? Comment on Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients. Nutrients 2019, 11, 1156”
Next Article in Special Issue
Dietary Habits, Vitamin and Mineral Supplements in Patients with Chronic Kidney Disease (CKD)
Previous Article in Journal
Use of Grape Pomace Phenolics to Counteract Endogenous and Exogenous Formation of Advanced Glycation End-Products
Previous Article in Special Issue
Lipid Accumulation and Chronic Kidney Disease
Review

Native Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice

1
Nephrology, Dialysis and Renal Transplantation, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy
2
Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy
3
Department of Internal Medicine n3, Ternopil State Medical University, 46002 Ternopil, Ukraine
4
Renal Division, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20122 Milan, Italy
*
Author to whom correspondence should be addressed.
Nutrients 2019, 11(8), 1918; https://doi.org/10.3390/nu11081918
Received: 5 July 2019 / Revised: 7 August 2019 / Accepted: 12 August 2019 / Published: 15 August 2019
Native hypovitaminosis D (n-hVITD) is frequently found from the early stages of chronic kidney disease (CKD) and its prevalence increases with CKD progression. Even if the implications of n-hVITD in chronic kidney disease-mineral bone disorder (CKD-MBD) have been extensively characterized in the literature, there is a lot of debate nowadays about the so called “unconventional effects” of native vitamin D (25(OH)VitD) supplementation in CKD patients. In this review, highlights of the dimension of the problem of n-hVITD in CKD stages 2–5 ND patients will be presented. In addition, it will focus on the “unconventional effects” of 25(OH)VitD supplementation, the clinical impact of n-hVITD and the most significant interventional studies regarding 25(OH)VitD supplementation in CKD stages 2–5 ND. View Full-Text
Keywords: vitamin D; mineral metabolism; CKD; cardiovascular risk; vitamin D supplementation vitamin D; mineral metabolism; CKD; cardiovascular risk; vitamin D supplementation
Show Figures

Figure 1

MDPI and ACS Style

Alfieri, C.; Ruzhytska, O.; Vettoretti, S.; Caldiroli, L.; Cozzolino, M.; Messa, P. Native Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice. Nutrients 2019, 11, 1918. https://doi.org/10.3390/nu11081918

AMA Style

Alfieri C, Ruzhytska O, Vettoretti S, Caldiroli L, Cozzolino M, Messa P. Native Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice. Nutrients. 2019; 11(8):1918. https://doi.org/10.3390/nu11081918

Chicago/Turabian Style

Alfieri, Carlo, Oksana Ruzhytska, Simone Vettoretti, Lara Caldiroli, Mario Cozzolino, and Piergiorgio Messa. 2019. "Native Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice" Nutrients 11, no. 8: 1918. https://doi.org/10.3390/nu11081918

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop